AZD5492 Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 1: 1Phase 1/2: 1

Top Sponsors

AstraZeneca2

Indications

Systemic Lupus Erythematosus1
B-cell Malignancies1
Idiopathic Inflammatory Myopathies1
Lupus1
Arthritis1

Anniston, Alabama1 trial

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.

Research Site

Phase 1

La Jolla, California1 trial

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Research Site

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.